Estimaciones de analistas de Wall Street para Benitec Biopharma Inc. (BNTC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 6 |
| Mantener | 1 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 0.86 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-13 | $-0.27 | ||
| 2026-09-14 | $-0.26 | $-0.26 | +1.6% |
| 2026-05-14 | $-0.24 | $-0.27 | +11.1% |
| 2026-02-12 | $-0.26 | $-0.23 | -13.0% |
| 2025-11-14 | $-0.22 | $-0.35 | +37.1% |
| 2025-09-22 | $-0.42 | $-0.28 | -50.0% |
| 2025-05-14 | $-0.24 | $-0.36 | +33.3% |
| 2025-02-14 | $-0.36 | $-1.00 | +64.0% |
Ratios de valoración
| Precio / Valor contable | 2.86 |
| EV / EBITDA | -4.39 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $195882 | $4.4M | $17.4M | $97000 | $59000 | $73000 | $75000 | 0 | 0 | 0 |
| Coste de Ventas | $159999 | $473965 | $622173 | -$185000 | $123000 | $9000 | 0 | $343000 | $396000 | $481000 |
| Beneficio Bruto | $35881 | $3.9M | $15.9M | $282000 | -$64000 | $64000 | $75000 | -$343000 | -$396000 | -$481000 |
| I+D | $4.1M | $3.7M | $3.2M | $3.0M | $7.0M | $11.3M | $12.8M | $15.6M | $18.3M | $23.4M |
| Generales y Administrativos | $5.4M | $4.7M | $3.2M | $5.6M | $6.5M | $6.6M | $6.4M | $7.0M | $23.4M | $27.8M |
| Gastos Operativos | $12.2M | $16.6M | $13.1M | $8.6M | $13.5M | $17.9M | $19.2M | $22.5M | $41.4M | $50.7M |
| Beneficio Operativo | -$15.9M | -$8.7M | $3.7M | -$8.3M | -$13.6M | -$17.9M | -$19.1M | -$22.5M | -$41.8M | -$51.2M |
| EBITDA | -$3.2M | -$6.3M | $1.9M | -$7.9M | -$13.5M | -$17.8M | -$18.7M | -$22.1M | -$41.4M | -$51.2M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $6000 | $32000 | $33000 | 0 | -$3.3M | 0 |
| Beneficio Antes de Impuestos | -$3.3M | -$8.6M | $3.7M | -$8.3M | -$13.9M | -$18.2M | -$19.6M | -$21.8M | -$37.9M | -$45.5M |
| Impuestos | -$10.3M | -$4.2M | -$926824 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.6M | -$12.3M | $3.7M | -$8.3M | -$13.9M | -$18.2M | -$19.6M | -$21.8M | -$37.9M | -$45.5M |
| BPA | $-63.55 | $-103.60 | $28.45 | $-69.09 | $-27.27 | $-19.31 | $-14.12 | $-2.68 | $-1.05 | $-0.98 |
| BPA Diluido | $-63.55 | $-103.60 | $28.45 | $-8.10 | $-27.27 | $-19.31 | $-14.12 | $-2.68 | $-1.05 | $-0.98 |
| Acciones en Circulación (Diluidas) | $137596 | $165064 | $201592 | $240280 | $1.0M | $1.9M | $1.4M | $10.3M | $36.2M | $46.6M |
Precio
| Precio | $11.04 |
| Capitalización | $379M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AUTL · GALT · IMAB · LCTX · NGNE · OCGN · PRTC
Explorar sector: Healthcare · Biotechnology
Más secciones de BNTC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones